Kara, Mete, et al. “Real-World Outcomes of Baricitinib Monotherapy Versus CsDMARD Combination Therapy in Rheumatoid Arthritis: A SingleCenter Retrospective Analysis of Efficacy, Safety, and Drug Retention”. Archives of Rheumatology, vol. 40, no. 3, Sept. 2025, pp. 279-87, doi:10.5152/ArchRheumatol.2025.11131.